|4Oct 2, 4:37 PM ET

Dudley Robert Michael 4

4 · Transcode Therapeutics, Inc. · Filed Oct 2, 2023

Insider Transaction Report

Form 4
Period: 2023-09-28
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2023-09-28$0.51/sh+98,000$49,980180,262 total
Footnotes (1)
  • [F1]Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.

Documents

1 file
  • 4
    tm2327413-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT